AbbVie Inc (ABBV)
159.59
-7.70
(-4.60%)
USD |
NYSE |
Apr 26, 16:00
160.00
+0.41
(+0.26%)
After-Hours: 18:07
AbbVie Cash from Financing (TTM): -17.22B for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -17.22B |
September 30, 2023 | -22.41B |
June 30, 2023 | -25.26B |
March 31, 2023 | -24.02B |
December 31, 2022 | -24.80B |
September 30, 2022 | -21.51B |
June 30, 2022 | -19.63B |
March 31, 2022 | -22.84B |
December 31, 2021 | -19.04B |
September 30, 2021 | -16.40B |
June 30, 2021 | -15.57B |
March 31, 2021 | -12.25B |
December 31, 2020 | -11.50B |
September 30, 2020 | 18.80B |
June 30, 2020 | 21.17B |
March 31, 2020 | 21.67B |
December 31, 2019 | 18.71B |
September 30, 2019 | -11.72B |
June 30, 2019 | -10.36B |
March 31, 2019 | -17.27B |
December 31, 2018 | -14.40B |
September 30, 2018 | -12.50B |
June 30, 2018 | -14.22B |
March 31, 2018 | -6.227B |
December 31, 2017 | -5.512B |
Date | Value |
---|---|
September 30, 2017 | -6.086B |
June 30, 2017 | -6.647B |
March 31, 2017 | -4.503B |
December 31, 2016 | -3.928B |
September 30, 2016 | -3.857B |
June 30, 2016 | -3.542B |
March 31, 2016 | 5.463B |
December 31, 2015 | 5.752B |
September 30, 2015 | 7.301B |
June 30, 2015 | 7.638B |
March 31, 2015 | -2.946B |
December 31, 2014 | -3.293B |
September 30, 2014 | -3.158B |
June 30, 2014 | -3.052B |
March 31, 2014 | -3.137B |
December 31, 2013 | -3.442B |
September 30, 2013 | -306.00M |
June 30, 2013 | 2.551B |
March 31, 2013 | 1.725B |
December 31, 2012 | 1.931B |
September 30, 2012 | -2.019B |
June 30, 2012 | -6.514B |
March 31, 2012 | -6.963B |
December 31, 2011 | -6.783B |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-25.26B
Minimum
Jun 2023
21.67B
Maximum
Mar 2020
-10.22B
Average
-16.40B
Median
Sep 2021
Cash from Financing (TTM) Benchmarks
Amgen Inc | 21.05B |
Immunogen Inc (DELISTED) | 495.80M |
Johnson & Johnson | -15.82B |
Eli Lilly and Co | 3.496B |
Merck & Co Inc | -4.81B |